taurine has been researched along with Bacterial Infections, Gram-Positive in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurolidine-citrate use did not decrease all-cause bacteremia and was associated with a greater need for thrombolytic treatment." | 9.14 | A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. ( Al-Sayed, T; Bhat, R; Cheesbrough, JS; Curry, A; Diggle, P; Ebah, L; Heap, M; Millband, N; Mitra, S; Saxena, R; Schulz, M; Solomon, LR; Waterhouse, D, 2010) |
| "Taurolidine-citrate use did not decrease all-cause bacteremia and was associated with a greater need for thrombolytic treatment." | 5.14 | A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. ( Al-Sayed, T; Bhat, R; Cheesbrough, JS; Curry, A; Diggle, P; Ebah, L; Heap, M; Millband, N; Mitra, S; Saxena, R; Schulz, M; Solomon, LR; Waterhouse, D, 2010) |
| "All 6 subjects with bacterial conjunctivitis were cured within 3-5 days." | 2.69 | Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study. ( Gottardi, W; Nagl, M; Pöttinger, E; Teuchner, B; Ulmer, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simon, A | 1 |
| Ammann, RA | 1 |
| Wiszniewsky, G | 1 |
| Bode, U | 1 |
| Fleischhack, G | 1 |
| Besuden, MM | 1 |
| Solomon, LR | 1 |
| Cheesbrough, JS | 1 |
| Ebah, L | 1 |
| Al-Sayed, T | 1 |
| Heap, M | 1 |
| Millband, N | 1 |
| Waterhouse, D | 1 |
| Mitra, S | 1 |
| Curry, A | 1 |
| Saxena, R | 1 |
| Bhat, R | 1 |
| Schulz, M | 1 |
| Diggle, P | 1 |
| Nagl, M | 1 |
| Teuchner, B | 1 |
| Pöttinger, E | 1 |
| Ulmer, H | 1 |
| Gottardi, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non[NCT02279121] | 162 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for taurine and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Topics: Adult; Aged; Anti-Infective Agents; Anticoagulants; Bacteremia; Catheters, Indwelling; Citric Acid; | 2010 |
Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Conjunctivitis, Bacterial; Conjunctivitis, Viral; Female; | 2000 |
1 other study available for taurine and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients.
Topics: Adolescent; Adult; Anti-Infective Agents; Catheterization, Central Venous; Child; Child, Preschool; | 2008 |